Maastricht 2017 Meeting Highlights Registration Programme Overview Exhibition Virtual Exhibition Hotels Satellite Meetings Visa Letter Application Star Alliance Travel Discount

10 - 12 February 2017, MECC Maastricht,The Netherlands.

This Meeting has been awarded 15 CME credits.

MAGS: magnifying surgery - arising of a new special field in cataract surgery

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Session Details

Session Title: Cataract
Session Date/Time: Saturday 11/02/2017 | 08:30-11:00
Paper Time: 10:48
Venue: Auditorium 1

First Author: A. Borkenstein AUSTRIA
Co Author(s): E. Borkenstein                  

Abstract Details


To assess the clinical outcomes of implanting a magnifying high add IOL in eyes with progressed ARMD and cataract. To determine the value of the Lentis MAX LS-313 MF80 (Oculentis, Germany) in enhancing quality of life and the individual independence in daily routine. To change the antiquated mindset regarding hopeless, unpromising cases!


Borkenstein & Borkenstein Praxis f�r Augenheilkunde und Optometrie, Privatklinik der Kreuzschwestern Graz, Austria.


In this case series subjects with clinical significant cataract and progressed dry ARMD (stable in OCT > 3 months) with BCDVA of 1.3 -0.5 logMAR were included. In all cases the aspheric, biconvex, sector shaped foldable one-piece IOL (Lentis MAX LS-313 MF80, Oculentis Germany) with an IOL add power of 8.0 dpt. (= 6.0 dpt. spectacle plane) was implanted in the dominant eye.


The postoperative results were divided into objective measured (BCNVA, BCDVA, OCT) and subjective measured (quality of life, independence, autonomy in daily routine) with a points-based system score. The BCDVA improved in all cases immediately after surgery, UCNVA improved in all cases but requires more time (training, neuroadaption). No halos or glare were reported. ARMD (OCT) was stable in the postoperative course of 6 months.


We can report from a very high patient satisfaction. All subjects ranked their quality of life higher than before. Our subjective and objective measured results show that continuing improvement of independence can be achieved with training in the first 3-6 months after surgery. Implanting a high add IOL is a promising alternative in low-vision patients with late ARMD and cataract.

Financial Disclosure:


Back to previous